Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gene Editing

329.32
-6.9443-2.07%
Number of Gainers:1
Number of Losers:4
Number of Flat:1
PE:- -
High:334.90
Open:334.41
Low:325.30
Close:336.26
Loading ...

US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies

MT Newswires Live
·
2 hours ago

Sui Ecosystem Token Sees Widespread Price Surge, CETUS Up 36% in 24 Hours

Blockbeats
·
Yesterday

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks
·
24 Apr

Crispr Therapeutics AG: Promising Growth with Casgevy Launch and Innovative Pipeline

TIPRANKS
·
22 Apr

Trump's FDA Sends a Bullish Signal to Biotech -- Heard on the Street -- WSJ

Dow Jones
·
22 Apr

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks
·
21 Apr

JOHNNIE WALKER ESTABLISHES A NEW STANDARD IN DESIGN INNOVATION BY INTRODUCING BLUE LABEL ULTRA, THE WORLD'S LIGHTEST WHISKY BOTTLE

PR Newswire
·
18 Apr

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks
·
18 Apr

Crispr Therapeutics AG (CRSP) Receives a Buy from Bank of America Securities

TIPRANKS
·
17 Apr

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

Simply Wall St.
·
17 Apr

Bluebird Bio Reaffirms Support for Carlyle Deal Amid Lack of Binding Offer From Ayrmid

MT Newswires Live
·
16 Apr

Shares of bluebird bio Down 9% After Ayrmid Fails to Give Binding Offer

THOMSON REUTERS
·
16 Apr

BUZZ-Bluebird Bio falls after Ayrmid fails to give binding offer

Reuters
·
16 Apr

bluebird bio Shares Down 7.9% at $4.12 Premarket After Ayrmid Fails to Give Binding Offer

THOMSON REUTERS
·
16 Apr

BRIEF-Bluebird Bio Confirms That Ayrmid, Has Not Delivered A Binding Offer Or Obtained Necessary Financing Despite Extensive Engagement

Reuters
·
16 Apr

NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc.

TIPRANKS
·
14 Apr

Beam Therapeutics Inc.'s (NASDAQ:BEAM) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures

Simply Wall St.
·
11 Apr

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

Zacks
·
11 Apr